| Period Ending: |
LTM
(Last Twelve Months) |
2024 12-31 |
2023 12-31 |
2022 12-31 |
2021 12-31 |
|---|---|---|---|---|---|
| Report Filing | 2024-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 25.95 | 25.95 | 19.29 | 20.03 | 17.32 |
| Research & Development | 0 | 0 | 8.31 | 14.27 | 12.35 |
| Selling, General and Administrative | 9.3 | 9.3 | 9.46 | 5.65 | 4.94 |
| Other Operating Expenses | 16.65 | 16.65 | 1.51 | 0.116 | 0.036 |
| Operating Income | -25.95 | -25.95 | -19.29 | -20.03 | -17.32 |
| Net Non-Operating Interest | 0.8 | 0.8 | 1.76 | 1.03 | 0.088 |
| Interest Income | 0.809 | 0.809 | 1.77 | 1.05 | 0.101 |
| Interest Expense | 0.009 | 0.009 | 0.013 | 0.012 | 0.013 |
| Equity & Other Income/(Expense) | 0 | 0 | -0.038 | -0.109 | 0.031 |
| Income Before Tax | -25.15 | -25.15 | -17.57 | -19.11 | -17.2 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 |
| Income Attributable to Non-Controlling Interest | 0 | 0 | 0 | 0 | 0 |
| Net Income | -25.15 | -25.15 | -17.57 | -19.11 | -17.2 |
| Depreciation and Amortization | 0.161 | 0.161 | 0.212 | 0.404 | 0.205 |
| EBITDA | -25.79 | -25.79 | -19.07 | -19.63 | -17.12 |
| Earnings Per Share (EPS) | -4.3 | -4.3 | -3 | -3.37 | -3.03 |
| Diluted Earnings Per Share | -4.3 | -4.3 | -3 | -3.37 | -3.03 |
| Weighted Average Shares Outstanding | 5.85 | 5.85 | 5.85 | 5.67 | 5.67 |
| Diluted Weighted Average Shares Outstanding | 5.85 | 5.85 | 5.85 | 5.67 | 5.67 |
